DurgicalDurgical
EN
Open the app

Esomeprazole !

The S-isomer of omeprazole, a proton pump inhibitor given by mouth or IV. Like omeprazole, it inhibits CYP2C19 and is avoided with clopidogrel.

Updated 2026-11-01

The crystal is the pig gastric pump bound to vonoprazan, a reversible acid blocker; the figure highlights Cys813, the cysteine to which activated esomeprazole bonds covalently.

Target in 3D: Gastric H⁺/K⁺-ATPase (proton pump), α subunit. PDB structure 5YLU (RCSB PDB, public domain). View the structure at RCSB PDB

Mechanism of action

Esomeprazole is the S-enantiomer of omeprazole. Like the other PPIs it is a prodrug that collects in the acidic canaliculus of the parietal cell, is converted by acid into a reactive sulfenamide and bonds covalently to cysteines of the H⁺/K⁺-ATPase, blocking the final step of acid secretion until new pumps are made. It also inhibits CYP2C19 in a time-dependent way, so its own levels rise with repeated doses.

  1. The S-isomer of omeprazole collects in the parietal cell canaliculus
  2. Acid activates it into a reactive sulfenamide
  3. A covalent bond to Cys813 locks the H⁺/K⁺ pump
  4. Acid falls until the cell makes new pumps

Pharmacokinetics

Absorption
Delayed-release forms; food lowers absorption markedly, so it is taken at least an hour before a meal. IV forms exist.
Metabolism
Liver, by CYP2C19 and CYP3A4; it inhibits CYP2C19 itself, so exposure rises more than proportionally with repeated doses.
Elimination
About 80% leaves as inactive metabolites in the urine and the rest in the faeces.
Half-life
Short in plasma, but the effect on the pump lasts much longer.

Indications

Adverse effects

Common

  • Headache
  • Diarrhoea, nausea, abdominal pain, flatulence and constipation
  • Dry mouth

Contraindications

  • Hypersensitivity to esomeprazole or other substituted benzimidazoles
  • Use with rilpivirine-containing products

Key interactions

Clopidogrel
Esomeprazole inhibits CYP2C19, reduces clopidogrel's active metabolite and weakens platelet inhibition; the combination is avoided.
Citalopram
Higher citalopram exposure and more risk of QT prolongation.
Cilostazol and digoxin
Higher exposure to these drugs.
Atazanavir and nelfinavir
Lower antiretroviral levels, loss of effect and resistance; nelfinavir is avoided with it.
Rifampicin and St John's wort
They induce CYP2C19 and CYP3A4 and markedly lower esomeprazole levels.

What is monitored

  • Magnesium before and during long treatment, especially with digoxin or diuretics
  • Kidney function if fever, rash or rising creatinine appear
  • Periodic review of whether it is still needed

Administration and safety

  • Taken at least an hour before a meal, because food lowers absorption
  • Capsules are swallowed whole; delayed-release forms are not crushed or chewed
  • Check for clopidogrel in the medication list; another PPI or an H2 blocker may be preferred
  • IV forms are used when oral intake is not possible

Nursing care

  • Schedule the dose before breakfast
  • Review the medication list for clopidogrel, citalopram and antiretrovirals
  • Check magnesium in long-term use, mainly with diuretics or digoxin
  • Teach the patient to report watery diarrhoea, fever or rash

Pregnancy and breastfeeding

Epidemiological data on esomeprazole and omeprazole have not shown more major malformations; it is used when needed.

Test yourself

Think of the answer, then tap the question to see it.

How is esomeprazole related to omeprazole?

It is omeprazole's S-enantiomer (S-isomer).

Why is esomeprazole avoided in a patient on clopidogrel?

It inhibits CYP2C19, which converts clopidogrel into its active metabolite, so platelet inhibition is weaker.

Why is esomeprazole taken at least an hour before a meal?

Food markedly lowers its absorption.

Add to my cards (3)

← Back to the class: Proton pump inhibitors (PPIs)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - ESOMEPRAZOLE MAGNESIUM capsule, delayed release pellets (DailyMed (U.S. National Library of Medicine), 2026); Esomeprazole: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); Medications for the Treatment of Gastric Acidity - Gastroenterology - MSD Manual Professional Edition (MSD Manual Professional Edition, 2025); RCSB PDB - 5YLU: Crystal structure of the gastric proton pump complexed with vonoprazan (RCSB Protein Data Bank, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.